HashiCorp Inc
NASDAQ:HCP
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
HashiCorp Inc
NASDAQ:HCP
|
US |
|
G1 Therapeutics Inc
NASDAQ:GTHX
|
US |
|
R
|
Rentokil Initial PLC
NYSE:RTO
|
UK |
|
M
|
MEP Corporation PCL
SET:MEB
|
TH |
|
Welltower Inc
NYSE:WELL
|
US |
|
W
|
Whirlpool Corp
DUS:WHR
|
US |
|
Consumer Portfolio Services Inc
NASDAQ:CPSS
|
US |
|
D
|
Deckers Outdoor Corp
XBER:DO2
|
US |
|
B
|
Bank of the Philippine Islands
XPHS:BPI
|
PH |
|
Z
|
Zurich Insurance Group AG
XBER:ZFI1
|
CH |
|
D
|
Discovery Ltd
JSE:DSY
|
ZA |
|
CONSOL Energy Inc
NYSE:CEIX
|
US |
|
S
|
Supreme Petrochem Ltd
NSE:SPLPETRO
|
IN |
|
E
|
Eli Lilly and Co
SWB:LLY
|
US |
|
A
|
AXA SA
XHAM:AXA
|
FR |
|
Commercial Metals Co
NYSE:CMC
|
US |
|
Gateley Holdings PLC
LSE:GTLY
|
UK |
|
A
|
Avalon Technologies Ltd
NSE:AVALON
|
IN |
|
Barrick Gold Corp
TSX:ABX
|
CA |
|
Beigene Ltd
SSE:688235
|
KY |
|
Mckesson Corp
NYSE:MCK
|
US |
|
Minesto AB
F:7MN
|
SE |
|
Grenke AG
XETRA:GLJ
|
DE |
|
LyondellBasell Industries NV
NYSE:LYB
|
UK |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is HCP's stock price target?
Not Available
HCP does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for HashiCorp Inc?
Projected CAGR
15%
Over the last 4 years, the compound annual growth rate for Revenue has been 48%. The projected CAGR for the next 3 years is 15%.